NuSirt Biopharma launching new clinical trial
NuSirt Biopharma, a company founded by Michael Zemel in Knoxville several years ago, has announced plans to launch a clinical trial to determine if its patented technology is a potential treatment for non-alcoholic fatty liver disease and steatohepatitis. The start-up, now based in Nashville, still maintains its research facilities here. For more information about the trial plans, read the news release. For our three-part series on the company, here are the links: Part 1, Part 2, and Part 3.
